Tag: genomics
-
FDA Clears Genomic Bone Marrow Test for Low-Level Cancer
1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual disease levels in people…
-
Genome Centers Named for Precision Medicine Program
Three medical research centers in the U.S. will begin analyzing the DNA in specimen samples from participants in a large-scale precision medicine initiative conducted by National Institutes of Health.
-
Synthetic Antibody Neutralizing Gluten in Development
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten.
-
Liquid Biopsy for Solid Tumors Now Available
A test that inspects a patient’s blood sample for characteristic indicators of solid-tumor cancer, and can be part of a comprehensive precision analytics program, is now on the market.
-
App Offers Fast, Inexpensive Urinary Tract Infection Test
A system for identifying bacterial infections shows the system’s smartphone app and accompanying lab kit can detect urinary tract infections, including those with sepsis, in about an hour.
-
Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses
The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses.
-
Trial Testing Universal Nasal Spray Flu Vaccine in Children
A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types.
-
NIH Grant Aims to Make Drugs Taste Better, Not Bitter
A new award from National Institutes of Health funds a study to identify components in taste bud cells that block bitter taste sensations encountered in some drugs and foods.
-
Gilead Gains Genome-Editing Hepatitis B Therapy
Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver.
-
Personalized Breast Cancer Trial Advances 7 Drugs
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA.